| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ESTA
Establishment Labs Holdings
|
Aug 14, 2026 | BUY |
Strong Buy
+16.3% avg upside
12 analysts
|
$117.00
47.26% Upside
|
+0.0% | · |
|
MDWD
Mediwound
|
Aug 14, 2026 | BUY |
Strong Buy
+59.4% avg upside
13 analysts
|
$25.00
84.35% Upside
|
+0.0% | · |
|
STXS
Stereotaxis
|
Aug 12, 2026 | BUY |
Strong Buy
+171.7% avg upside
7 analysts
|
$3.00
117.39% Upside
|
-1.4% | · |
|
HUMA
Humacyte
|
Aug 12, 2026 | BUY |
Strong Buy
+1023.4% avg upside
11 analysts
|
$1.25
106.72% Upside
|
-9.0% | · |
|
RCEL
Avita Medical
|
Aug 07, 2026 | BUY |
Strong Buy
+35.8% avg upside
11 analysts
|
$12.00
52.83% Upside
|
+1.0% | · |
|
OM
Outset Medical
|
Aug 07, 2026 | BUY |
Buy
+273.6% avg upside
8 analysts
|
$10.00
121.75% Upside
|
-8.0% | · |
|
SENS
Senseonics Holdings
|
Aug 07, 2026 | BUY |
Buy
+91.8% avg upside
13 analysts
|
$15.00
92.05% Upside
|
+11.2% | · |
|
BDX
Becton Dickinson
|
Aug 07, 2026 | HOLD |
Buy
+7.1% avg upside
25 analysts
|
$182.00
0.68% Downside
|
+2.9% | · |
|
PRCT
PROCEPT BioRobotics
|
Aug 05, 2026 | BUY |
Buy
+47.2% avg upside
17 analysts
|
$28.00
29.26% Upside
|
+11.9% | · |
|
CBLL
Ceribell, Inc.
|
Aug 05, 2026 | BUY |
Strong Buy
+8.0% avg upside
8 analysts
|
$29.00
24.33% Upside
|
+27.6% | · |
|
TMDX
TransMedics Group
|
Aug 05, 2026 | BUY |
Strong Buy
+15.7% avg upside
15 analysts
|
$120.00
35.47% Upside
|
+15.8% | · |
|
BAX
Baxter International
|
Jul 31, 2026 | HOLD |
Buy
+25.0% avg upside
23 analysts
|
$29.00
8.41% Upside
|
+3.4% | · |
|
CERS
Cerus
|
Jul 31, 2026 | BUY |
Strong Buy
+81.9% avg upside
10 analysts
|
$5.00
67.70% Upside
|
+26.1% | · |
|
VCEL
Vericel
|
Jul 31, 2026 | BUY |
Strong Buy
+7.0% avg upside
16 analysts
|
$58.00
31.16% Upside
|
-3.5% | · |
|
BSX
Boston Scientific
|
Jul 30, 2026 | BUY |
Strong Buy
+30.8% avg upside
38 analysts
|
$56.00
8.14% Upside
|
+12.7% | · |
|
DXCM
Dexcom
|
Jul 30, 2026 | BUY |
Strong Buy
+17.8% avg upside
32 analysts
|
$95.00
5.88% Upside
|
+20.4% | · |
|
ABT
Abbott Laboratories
|
Jul 28, 2026 | BUY |
Strong Buy
+4.3% avg upside
36 analysts
|
$115.00
3.44% Upside
|
+3.7% | · |
|
EW
Edwards Lifesciences
|
Jul 23, 2026 | BUY |
Strong Buy
+9.6% avg upside
34 analysts
|
$104.00
13.49% Upside
|
+9.3% | · |
|
MDT
Medtronic
|
Jul 10, 2026 | BUY |
Buy
+5.6% avg upside
38 analysts
|
$100.00
9.53% Upside
|
+8.8% | · |
|
AVR
Anteris Technologies Global Corp.
|
Jun 29, 2026 | BUY |
Strong Buy
+55.4% avg upside
5 analysts
|
$15.00
59.67% Upside
|
-3.9% | · |
|
BFLY
Butterfly Network
|
Jun 18, 2026 | BUY |
Strong Buy
-38.3% avg upside
8 analysts
|
$6.00
32.06% Downside
|
-0.7% | · |
|
OBIO
Orchestra BioMed Holdings
|
May 13, 2026 | BUY |
Strong Buy
+202.7% avg upside
9 analysts
|
$15.00
240.22% Upside
|
+8.6% | · |
|
JNJ
Johnson & Johnson
|
Apr 23, 2026 | BUY |
Strong Buy
-8.8% avg upside
39 analysts
|
$250.00
3.99% Downside
|
+13.5% | · |
|
ATEC
Alphatec Holdings
|
Jan 23, 2026 | BUY |
Strong Buy
+70.7% avg upside
23 analysts
|
$20.00
104.28% Upside
|
-37.3% | · |
|
PODD
Insulet
|
Dec 04, 2025 | BUY |
Strong Buy
+51.3% avg upside
32 analysts
|
$379.00
164.37% Upside
|
-54.6% | · |
|
SYK
Stryker
|
Nov 13, 2025 | BUY |
Strong Buy
+8.8% avg upside
37 analysts
|
$435.00
28.30% Upside
|
-7.9% | · |
|
RBOT
Vicarious Surgical
|
Nov 13, 2025 | BUY |
Buy
+20733.4% avg upside
6 analysts
|
— | -98.3% | · |
|
ALURD
Allurion Technologies
|
Nov 12, 2025 | BUY |
Strong Buy
+2732.9% avg upside
4 analysts
|
$90.00
2494.99% Upside
|
+131.2% | · |
|
TNDM
Tandem Diabetes Care
|
Nov 06, 2025 | BUY |
Buy
+44.2% avg upside
29 analysts
|
$20.00
12.05% Downside
|
+70.4% | · |
|
ZBH
Zimmer Biomet Holdings
|
Nov 05, 2025 | HOLD |
Buy
+13.6% avg upside
38 analysts
|
$99.00
1.57% Downside
|
+15.9% | · |
|
CTSO
Cytosorbents
|
Jan 12, 2024 | HOLD |
Strong Buy
+2874.1% avg upside
13 analysts
|
— | -5.6% | · |
|
ARAY
Accuray
|
Jan 12, 2024 | HOLD |
Buy
+2137.8% avg upside
9 analysts
|
— | -24.4% | · |
|
TSE:PRN
Profound Medical
|
Oct 16, 2023 | BUY |
Strong Buy
+104.9% avg upside
11 analysts
|
$24.98
171.43% Upside
|
-17.6% | · |
|
ELUT
Elutia
|
Mar 04, 2022 | BUY |
Strong Buy
+801.6% avg upside
5 analysts
|
$13.00
1281.46% Upside
|
-36.8% | · |
|
GILD
Gilead Sciences
|
Oct 29, 2020 | BUY |
Strong Buy
-14.0% avg upside
66 analysts
|
$80.00
42.10% Downside
|
+15.7% | · |
|
VIVE
Viveve Medical
|
Nov 09, 2018 | BUY |
Hold
+79999900.0% avg upside
8 analysts
|
$400.00
199999899.91% Upside
|
· | · |
|
OCGN
Ocugen
|
Sep 27, 2018 | BUY |
Strong Buy
+585.7% avg upside
17 analysts
|
$3.50
159.32% Upside
|
· | · |
|
ADYX
Adynxx
|
Aug 10, 2017 | BUY |
Strong Buy
+3387400.1% avg upside
4 analysts
|
$0.75
749900.10% Upside
|
· | · |
|
NUWE
Nuwellis
|
Mar 18, 2015 | BUY |
Strong Buy
+1640.5% avg upside
7 analysts
|
$9.00
587.02% Upside
|
· | · |
|
IMRSQ
IMRIS
|
Aug 30, 2013 | BUY |
Strong Buy
+289999899.9% avg upside
3 analysts
|
$3.50
349999899.98% Upside
|
· | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.